Oral Thin Films Drug Delivery Services

Oral thin films offer a convenient and non-invasive alternative to traditional oral dosage forms such as tablets and capsules. Protheragen-ING specializes in the development and formulation of innovative oral thin film drug delivery systems (DDS). Our experienced team of scientists and researchers is dedicated to advancing pharmaceutical technology and providing customized solutions for efficient and patient-friendly drug delivery.

Introduction to Oral Thin Film

An oral thin film is a film consisting of a single or multi-layer polymer matrix, usually applied in the mouth, designed to deliver drugs through the oral mucosa. These films are placed in the mouth where they rapidly dissolve or adhere to the mucosal surface, allowing the drug to be absorbed directly into the body's circulation. They are typically made of polymeric materials that are biocompatible and soluble.

Fig.1 Demonstration of common site for application of film in buccal and sublingual mucosa.Fig. 1 Demonstration of common site for application of film in buccal and sublingual mucosa. (Lam J.K.W, et al. 2014)

Advantages of Oral Thin Film DDS

Types of Oral Thin Film

We can offer the following three common types of Oral Thin Film agents developed to meet different drug delivery requirements.

Our Oral Thin Film Technical Services

We offer a comprehensive range of technical services for oral film drug delivery system development. Our services include:

Fig.2 Multilayered oral thin films.Fig. 2 Multilayered oral thin films. (Gupta M.S, et al. 2020)

Preparation Methods of Oral Thin Films

We use one or a combination of the following methods to prepare oral dissolving/disintegrating thin films:

If you are interested in oral thin film drug delivery system development or have any questions, please feel free to contact us. We look forward to working with you and providing you with quality oral thin film technology services.

References

  1. Lam J.K.W, et al. (2014). "Oral Transmucosal Drug Delivery for Pediatric Use." Adv Drug Deliv Rev, 73, 50-62.
  2. Gupta M.S, et al. (2020). "Orodispersible Thin Film: A New Patient-centered Innovation." Journal of Drug Delivery Science and Technology, 59, 101843.

Inquiry
HOURS

Daily: 9.30 AM–6.00 PM
Sunday : 9.30 AM–1.00 PM
Holidays: Closed

CONTACT US
  • Tel:
  • E-mail:
  • Address:
  • WhatsAPP
    WhatsAPP
Privacy Policy | Cookie Policy
Copyright © Protheragen-ING. All Rights Reserved.
dcat
Member of
dcat
Top